Ashwagandha, a popular herbal supplement marketed as a stress-buster, has been linked to liver damage and other health risks, according to a growing body of research. The herb, also known as 'Indian ginseng', has been widely used in traditional Indian medicine for centuries, but its safety profile has come under scrutiny in recent years.
A study published in the Journal of Clinical and Translational Research found that ashwagandha supplements caused liver damage in 10% of participants, with some experiencing severe symptoms. The researchers warned that the risks were particularly high for people taking high doses or combining the herb with other medications.
Regulatory bodies, including the UK's Medicines and Healthcare products Regulatory Agency (MHRA), are now calling for stricter safety testing and labelling of ashwagandha supplements. The MHRA has advised consumers to be cautious when taking the supplement, particularly if they have pre-existing liver conditions or are taking other medications.
Experts are also warning of the dangers of self-medication with ashwagandha, citing a lack of standardisation in the manufacturing process and a lack of clear labelling about potential side effects. 'We urge people to be cautious when taking ashwagandha supplements and to consult with a healthcare professional before doing so,' said a spokesperson for the MHRA.
The ashwagandha industry has responded to the warnings, with some companies already reformulating their products to reduce the risk of liver damage. However, experts say that more needs to be done to ensure the safety of consumers.